Plain-English translation of NCT07004582 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This trial is testing whether doctors can predict how your prostate cancer will respond to treatment by growing a miniature version of your tumor in the laboratory. Researchers will take a small sample of tumor tissue during your routine medical procedures and use it to create these mini-tumors, which can then be tested with different treatments to see what works best for you.
Prostate cancer varies greatly from person to person, and current treatments don't work equally well for everyone. Many men experience treatment failure or relapse after initial therapy. This research aims to solve that problem by creating a personalized prediction tool—your own mini-tumor model—so doctors can choose the most effective treatment specifically for your cancer before you start therapy.
You likely qualify if…
You likely don't qualify if…
You will participate as part of your normal prostate cancer treatment. When your doctor performs your scheduled procedure—either radiation implant therapy or a diagnostic biopsy—they will collect a small extra sample of tumor tissue that would otherwise be discarded. This tissue sample will be sent to the laboratory to grow mini-tumors, which researchers will then test with different treatments to determine what might work best for your specific cancer.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Netherlands